ArticleFrontiers in immunology2025

ALG3 as a prognostic biomarker and mediator of PD-1 blockade resistance in hepatocellular carcinoma.

Pengju Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.